These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11708036

  • 21. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, Covino M, Ravaioli M, Fagiuoli S, Gasbarrini G, Rapaccini GL.
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [Abstract] [Full Text] [Related]

  • 22. Percutaneous ablation for small hepatocellular carcinoma.
    Yin XY, Lu MD.
    Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):121-30. PubMed ID: 19351283
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM, López Monclús J, Gómez Cruz A, Rubio González E, Pérez Arangüena R, Boullosa Graña E, Garcia Suárez A, Pérez-Picouto JL, Fernández Ruiz M, Lucena de la Poza JL, Sánchez Turrión V, Cuervas-Mons Martínez V.
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [Abstract] [Full Text] [Related]

  • 24. Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm.
    Kurokohchi K, Hirai S, Ohgi T, Ono M, Yoshitake A, Ebara K, Kitamura Y, Kasai Y, Maeta T, Kiuchi T, Masaki T, Yoneyama H, Kohi F, Kuriyama S.
    Int J Oncol; 2006 Aug; 29(2):375-80. PubMed ID: 16820879
    [Abstract] [Full Text] [Related]

  • 25. [Hepatocellular carcinoma recurrence in PEI site--a case report].
    Ota H, Nagano H, Sakon M, Inoue T, Hayashi S, Kondo M, Arai I, Morimoto O, Yamamoto T, Nakamura M, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M.
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2421-4. PubMed ID: 12484090
    [Abstract] [Full Text] [Related]

  • 26. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 27. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 28. [Experience of radiofrequency ablation therapy for hepatocellular carcinoma].
    Iwauchi T, Yamada N, Amano R, Ohira M, Nishino H, Hirakawa K.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1663-5. PubMed ID: 16315902
    [Abstract] [Full Text] [Related]

  • 29. [Multiple hepatocellular carcinomas successfully treated by combined therapies].
    Ochiai T, Sonoyama T, Kikuchi S, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ueda Y, Otsuji E, Hagiwara A, Yamagishi H.
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1809-11. PubMed ID: 16315948
    [Abstract] [Full Text] [Related]

  • 30. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 31. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA, Ishii H, Murakami K, El-Kholy MR, Furuse J, El-Dorry A, El-Malah A.
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [Abstract] [Full Text] [Related]

  • 32. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
    Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S.
    Hepatogastroenterology; 2005 Sep; 52(65):1344-6. PubMed ID: 16201070
    [Abstract] [Full Text] [Related]

  • 33. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 34. [Non-Surgical tumor ablation of hepatocellular carcinoma].
    Koike Y, Omata M.
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
    [Abstract] [Full Text] [Related]

  • 35. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M, Covey AM, Gandhi R, Gonen M, Getrajdman GI, Brody LA, Fong Y, Jarnagin W, D'Angelica M, Blumgart L, DeMatteo R, Brown KT.
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [Abstract] [Full Text] [Related]

  • 36. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C, Corso R, Rampoldi A, Vinci M, Belli LS, Vangeli M, Solcia M, Castoldi C, Prisco C, Vanzulli A, Pinzello G.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [Abstract] [Full Text] [Related]

  • 37. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL, Tanaka K, Lau L, Komura S.
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [Abstract] [Full Text] [Related]

  • 38. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
    Shiina S, Tateishi R, Yoshida H, Kanai F, Omata M.
    Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
    [Abstract] [Full Text] [Related]

  • 39. [Percutaneous tumor ablation therapy for the advanced stage of HCC].
    Teratani T, Shiina S, Obi S, Hamamura K, Koike Y, Akamatsu M, Fujishima T, Tateishi R, Imai Y, Shiratori Y, Omata M.
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1496-500. PubMed ID: 11015992
    [Abstract] [Full Text] [Related]

  • 40. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review.
    Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM.
    Eur J Surg Oncol; 2005 May; 31(4):331-47. PubMed ID: 15837037
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.